Back
Seres Therapeutics Stock Price Chart
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
19
MCRB
Seres Therapeutics
Last Price:
0.76
Seasonality Move:
-11.95%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).- The current trend is relatively stagnant and MCRB is experiencing slight buying pressure.
Seres Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.62 | Buy |
| 20-day SMA: | 0.7 | Sell |
| 50-day SMA: | 0.87 | Sell |
| 200-day SMA: | 1.93 | Sell |
| 8-day EMA: | 0.63 | Sell |
| 20-day EMA: | 0.69 | Sell |
| 50-day EMA: | 0.84 | Sell |
| 200-day EMA: | 1.96 | Sell |
Seres Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 36.14 | Sell |
| Chaikin Money Flow: | 2569157 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.65 - 0.79) | Sell |
| Bollinger Bands (100): | (0.8 - 1.26) | Sell |
Seres Therapeutics Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seres Therapeutics Stock
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.62 while MCRB 8-day simple moving average is 0.62, which is a Buy signal.
- The stock price of MCRB is 0.62 while Seres Therapeutics 20-day SMA is 0.70, which makes it a Sell.
- Seres Therapeutics 50-day simple moving average is 0.87 while MCRB share price is 0.62, making it a Sell technically.
- MCRB stock price is 0.62 and Seres Therapeutics 200-day simple moving average is 1.93, creating a Sell signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
19
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy or a Sell?
-
Seres Therapeutics stock is rated a Sell
The current Seres Therapeutics [MCRB] share price is $0.62. The Score for MCRB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics Stock Info
Market Cap:
94.32M
Price in USD:
0.62
Share Volume:
4.18M
Seres Therapeutics 52-Week Range
52-Week High:
6.73
52-Week Low:
0.54
Sell
19
Seres Therapeutics (MCRB)
is a Sell
Seres Therapeutics Share Price Forecast
-
What is the Seres Therapeutics stock price today?
The Seres Therapeutics stock price is 0.62 USD today. -
Will MCRB stock go up or go down?
Seres Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Seres Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics is overvalued.
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.62 while MCRB 8-day exponential moving average is 0.63, which is a Sell signal.
- The stock price of MCRB is 0.62 while Seres Therapeutics 20-day EMA is 0.69, which makes it a Sell.
- Seres Therapeutics 50-day exponential moving average is 0.84 while MCRB share price is 0.62, making it a Sell technically.
- MCRB stock price is 0.62 and Seres Therapeutics 200-day simple moving average is 1.96, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics
Is Seres Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.23 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.30 per share.
Technical Analysis of Seres Therapeutics
Should I short Seres Therapeutics stock?
- MCRB Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Seres Therapeutics is a Sell
- Seres Therapeutics Relative Strength Index (RSI) is 36.14, which suggest Seres Therapeutics is oversold
- The Bollinger Bands (25) for Seres Therapeutics is (0.65 - 0.79), which suggest Seres Therapeutics is a Sell
- The Bollinger Bands (100) for Seres Therapeutics is (0.8 - 1.26), which suggest Seres Therapeutics is a Sell
* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.